Related Experiment Video
Updated: Aug 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical and genetic issues in familial dilated cardiomyopathy
Emily L Burkett1, Ray E Hershberger
1Division of Cardiology, Department of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OT 97239, USA.
Insights
Familial dilated cardiomyopathy (FDC) accounts for a significant portion of idiopathic dilated cardiomyopathy (IDC) cases. Early screening and genetic counseling are crucial for managing this complex genetic heart condition.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Idiopathic dilated cardiomyopathy (IDC) involves left ventricular dysfunction.
- Familial dilated cardiomyopathy (FDC) accounts for 20-50% of IDC cases.
- Existing genetic research identifies 16 genes for autosomal dominant FDC, but more are expected.
Purpose of the Study:
- To highlight the genetic complexity of FDC.
- To emphasize the importance of screening and genetic counseling for FDC.
- To discuss the potential of emerging genetic testing for presymptomatic diagnosis.
Main Methods:
- Review of current understanding of FDC genetics and clinical presentation.
- Discussion of diagnostic challenges including incomplete penetrance and heterogeneity.
- Recommendations for screening and genetic counseling protocols.
Main Results:
- FDC exhibits incomplete penetrance, variable expression, and locus/allelic heterogeneity.
- Screening of first-degree relatives can enable early detection and treatment.
- Genetic counseling is vital for family evaluations and managing patient anxiety.
Conclusions:
- Further genetic discoveries are anticipated for FDC.
- Early screening and genetic counseling are essential for managing FDC.
- Emerging genetic testing offers promise for presymptomatic diagnosis of FDC.
Abstract:
Idiopathic dilated cardiomyopathy (IDC) is characterized by left ventricular dilatation and systolic dysfunction after known causes have been excluded. Idiopathic dilated cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20% to 50% of IDC cases. Sixteen genes have been shown to cause autosomal dominant FDC, but collectively may account for only a fraction of genetic causation; it is anticipated that additional genes causative of FDC will be discovered. Familial dilated cardiomyopathy demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making clinical and genetic diagnosis complex. Echocardiographic and electrocardiographic screening of first-degree relatives of individuals with IDC and FDC is indicated, as detection and treatment are possible before the onset of advanced symptomatic disease. Genetic counseling for IDC and FDC is also indicated to assist with family evaluations for genetic disease and with the uncertainty and anxiety surrounding the significance of clinical and genetic evaluation. Genetic testing is not yet commonly available, but its emergence will provide new opportunities for presymptomatic diagnosis.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology

